chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lichen Planus disease; This spontaneous case was reported by a patient and describes the occurrence of LICHEN PLANUS (Lichen Planus disease) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904, 051B22A, 005C21A and 025B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Aug-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2022, the patient experienced LICHEN PLANUS (Lichen Planus disease). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and AMOXICILLIN for Hair loss, at a dose of solution. At the time of the report, LICHEN PLANUS (Lichen Planus disease) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2020, SARS-CoV-2 test: (Positive) Positive.         No concomitant medications was reported. It was reported that patient had no allergies. No other vaccines was given within 1 month prior to Moderna COVID-19 vaccine. Patient height was 5'5". It was stated that patient had rash on her head. She was losing her hair. AE has caused patient to seek medical care: doctor visit, dermatologist. The patient had not experienced a similar event in the past. The patient was treated with some creams.
Paresthesias in the hands B/L.  After 4 days she develops some low back pain and weakness in the legs with prolonged standing, walking > 100 yards, and climbing stairs.  On Oct 10, 2013 she developed left facial droop and difficulty closing the left eyelid. On Oct 14, 2013 a lumbar puncture confirmed the diagnosis of Guillain Barre.  On Oct 14 she started IVIG 23g daily x 5 days.
Headache; Dizziness; Fatigue; Nausea; Soreness/Possible (Left) Ovarian Cyst; Soreness/Possible (Left) Ovarian Cyst.; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 08Apr2021 at 13:30(at the age of 63-years-old) as a single dose for COVID-19 immunisation. The medical history included hypertension, irritable bowel syndrome (IBS), anxiety and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included propranolol (MANUFACTURER UNKNOWN), ibuprofen (ADVIL) and ALIVE womens multi, all for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 18Mar2021 at 13:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 13:45, the patient experienced headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events headache, dizziness, fatigue, nausea and soreness/possible (left) ovarian cyst were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
After receiving Anthrax, patient noted redness, swelling, itching in the area on 18 Sept 08.  Area is 11 x 11cm, faint erythema, mild tenderness at vaccine site.  Was given Zyrtec and Motrin.
After the injection (day after), it was swollen - a little bit and hot to the touch (at the injection site) and it lasted a day or so. The following week, I started to get back pain and I hadn't experienced back pain before and it was mostly lower back pain and I was feeling tired day after day and then I started feeling better but then I started having back pain again. I saw Dr. (Sept 9th) for a routine appt and I told her about my lower back pain issues. She prescribed a muscle relaxer and she said I had arthritis in my back  - she pulled up my old x-rays to see about it. She said we could do further tests later if it doesn't resolved.  The muscle relaxers worked and she recommended me to do ice and hot and stretching and I'm doing health care at home and it's much improved. Seems to be resolving at this time.
On unspecified dates, the child received his 1st, 2nd and 3rd injections of Engerix-B (lot ENG1473A2, ENG1473B2 and ENG1653B2). He also received DTP (Tri-Immunol), DTAP/DTP and Hib-Titer). The child's attorney alleged that "The highly toxic emissions of certain power production facilities in the environmental zone of the Plaintiff's heightened vulnerability to heavy metals poisoning and his compromised condition related to the mercury poisoning discussed above, he was and is unable to process heavy metals and suffers neurological compromise as a result of the heavy metals contributed by the fossil-fuel burning utilities. His impaired condition is compounded by these exposures and his injury is made worse by them...The Plaintiff was poisoned by the cumulative doses of mercury in the environment and, as a result, the Plaintiff now suffers and in the future will continue to suffer from the toxic neurological effects of mercury poisoning." The attorney further alleged that "After being injection with Thimerosal and inhaling mercury-relatedness, language and (he) had the following symptoms: severe learning disabilities, impairments in social relatedness, language and communication difficulties, abnormal movements, sensory dysfunction, depressions, anxiety, hearing loss, severe bowel dysfunction, and other severe health disorders. (His) problems are caused by Thimerosal and the mercury and/or other heavy metals contained therein." The "severe" learning disabilities, impairments in social relatedness, language difficulties, communication difficulties and mercury poisoning in this report are considered "Medically Serious".
Patient in for first dose. Staff became aware of undiluted vial of pediatric Pfizer.  The mother of the patient immediately notified of the error, educated on emergency precautions and when to take child to ER. Patient observed for 15 minutes. No AE immediately identified. No difficulty breathing. Circulation remained stable. Patient active and released from observation in stable condition. 2/8/2022, at 3:30, the mother was contacted to check on the patient. He remains stable. No report of difficulties; but has some fatigue and a "little bit of a sore arm." The mother was reminded of when to seek emergency care and encouraged to see provider if she had any concerns. Will continue to follow-up.
Recently I had the 3rd shot of Biontech vaccine and 3 days later I am diagnosed with a blood cloth in my left lower leg; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization complete but manufacturer unknown, don't have any health problems and didn't have any reaction to first 2 shots), for Covid-19 immunization, reaction(s): "No adverse event". The following information was reported: DEEP VEIN THROMBOSIS (medically significant), outcome "unknown", described as "Recently I had the 3rd shot of Biontech vaccine and 3 days later I am diagnosed with a blood cloth in my left lower leg". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.  Clinical course: Patient had the 3rd shot of Biontech vaccine and 3 days later patient diagnosed with a blood cloth in his left lower leg, Normally patient do not have any health problems and did not have any reaction after first 2 shots.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
1 hrs p/vax pt mottled color, cool extremities, agitation, jitteriness; given Epi; & oxygen therapy;
Punctate Lesion at injection site and a 3 inch by 4 inch area of warmth and redness.
No reported adverse event.  2nd COVID vaccine from primary series was given on day 15 instead of waiting for 21 days as recommended by guidelines
Subjective: 33-year-old G4 P3 @36w5d presents for admission due to fetal demise diagnosed in clinic earlier today.  Her pregnancy is complicated by hypothyroid, obesity, h/o LTCS with subsequent VBAC x 2, h/o GDM with normal screen this pregnancy, h/o preeclampsia in prior prgnancy, COVID this pregnancy. PNC with doctor.   Patient called the office this morning noting lack of fetal movement. She believes she felt baby last night but is unsure.  Possibly the last time was this weekend.  She denies contractions, vaginal bleeding, LOF, fever, chills.  Has mild HA now but that just started since being admitted.  BP in office 160/94.  Now normal.
swelling in arm from below injection site to above elbow, (+) redness, (+) warmth and skin tenderness, mild warmth, FROM at elbow and shoulder, mom reports similar sx occured with 1st dose given at different facility
During the two weeks after the first injection the Left shoulder continued with pain and increased in pain.  during these same two weeks he noticed gradual and increasing arm weakness and numbness in the outer arm and forearm to the hand.  The weakness is so severe that he could not bend the elbow to lift (flexion)the hand up, nor lift the shoulder forward or out.(no flexion or abduction). no new symptoms in the Right arm or either leg.  there is severe atrophy of the proximal musculature of the left shoulder and upper arm.
A physician reported that a 4 month old infant developed hives following immunization with Prevnar (dose 2). The infant experienced hives following Prevnar vaccination dose one at 2months of age. The hives were more "severe" after the second immunization. The infant had no difficulty breathing and did recover. No further information was provided. ADDITIONAL information received on 12/20/01: Prevanr, along with Tripedia and ActHib were administered on 09/28/01. The infant received IPV within 4 weeks. The event occurred on 09/30/2001 Date of birth, gender (male), name and address of the infant were also provided.
Round RASH Started on Right Cheek on 12/6/19. Started with Raised lesions on legs and buttock. Given Prelone & Benadryl. Hives should go away in a few days. Moisturize skin frequently. Will obtain Food Allergy Panel @ 1 yr WCC.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). There were no concomitant medications. Patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: Chest X-ray: which came back OK, notes: They did a chest X-ray, which came back OK; SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.Patient received treatment with Paxlovid, treatment start date: 06Jul2022, treatment stop date: 10Jul2022. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
She got her vaccine on 3/24/22 had vaccine, nothing happened, end of March 3/31/22 was sitting watching TV and then her hands started on pins and needles from her wrist to fingertips.  Her hands turned blue, reminded her of Raynaud's, and has not happened again.   Has severe RA, history of lupus and COPD.  She thought that her RA was acting up.  Since March when she lays down her left arm is on fire to where she cannot stand it, and her feet and her esophagus and whole body is on fire.  She has been tested for neuropathy and does not have that.  She is not going further with testing, is 81 and has to have a pacemaker changes on Monday.  Feels that on the day of the vaccine is when the problems started and will not go away.  It is only when she lays down, neuropathy symptoms but not having neuropathy.   She continues with the pins and tingling pains now from her shoulder to her fingertips but mostly from her shoulder to her elbow on the left.  The right arm burns as well but not as much.  If she lays on her back this seems to help, but she cannot sleep on her back.  She takes her Oxycodone and the feeling goes away.    She went to a rheumatologist and then asked why she wasn't at a neurologist.  She went to a neurologist who did nerve testing and all kinds of blood work.  She was sure she had neuropathy and he told her that she did not have that.  She was surprised to hear this, and wanted her to go to Phoenix and to get special testing and bone marrow testing, which she did not want to do as she is 81.  She told her new PCP that she will not have anymore testing done.    Both of her shoulders seem to be developing more pain, and feels that this burning is adding to her RA especially in her shoulders.  She burns from shoulder to shoulder in her back which she did not have that symptom prior to the vaccine.    She had her 2nd vaccine on 4/21/22 and did not have any problems with that.  She has had flu and pneumonia vaccines without any issues.
9:20 Feeling Itchy Heart rate 80  Blood pressure 112/68  9:30 symptoms better, apple juice given 9:37 heart rate 80  blood pressure 108|68 symptoms have stopped 9:40 No rash, hives or difficulty breathing.  Works at hospital to inform supervisor for any further problems
9:00 AM - TOUNGE STARTED FEELING NUMB  10:00 AM - TOUNGE CONTINUED TO FEEL NUMB AND A SWELLING FEELING STARTED 11:00 AM - TOUNGE CONTINUED TO FEEL NUMB AND STARTED FEELING SIGNIFICANTLY LARGER 11:30 - FAINTING OCCURED WHILE PATIENT WAS LAYING FLAT ON FLOOR NOON - TRANSPORTED TO HOSPITAL 1PM - EKG, BLOOD GLUCOSE PERFORMED - PATIENT RECIEVED BENEDRYL AND ORAL HYDRATION 1:30 PM - PATIENT FELT SWELLING WAS SUBSIDING BUT NUMBNESS STILL OCCURING  2PM - PATIENT STATED SWELLING AND NUMBNESS WAS GONE  REMAINED IN OBSERVATION 5PM - DISCHARGED FROM ER
Starting the day after vaccination, I began to feel common side effects such as fatigue, fever, and pain at the injection site. As these were described to me in the release form, I was not concerned with them and hoped they would resolve quickly. Over the second day post inoculation these symptoms worsened. Starting on day 2, I also began to experience daily headaches, nausea, and vomiting lasting a total of 7 days after onset of symptoms. Upon resolution of these symptoms, I began to notice a prominent feeling of tightness in my chest in the mid to lower sternum area. This pain in my chest worsened with increased heart rate from mild activities, for example, walking less than a mile on relatively flat pavement. The pain made me hesitant to go forward with the final dose of the series, but I went ahead. After the second dose, the pain in my chest did not worsen perceptibly, but it did not improve either. Every time my breathing would increase or my heart rate would increase, I would feel a slight burning sensation and/or tightness in that area of my chest. The chest pain finally resolved about 3 weeks after receiving my final vaccine dose.
about 5 to 10 mins after receiving vaccine pt felt dizzy, felt like she  was going to pass out, seemed like everything was moving in slow motion.  gradually developed some shortness of breath, nausea, (gagged but without vomiting), and within 30 mins lips felt numb , mild headache, no chest pain, felt like heat rate was beating fast but was 70bpm. 30 mins after receiving vaccine gave pt 1 25mg Benadryl  had reaction to flu shot 2-3 years ago  with shortness of breath, itchy throat, and went to hospital via ambulance with symptoms resolving.  after 2hr pt was given  one more dose of 25mg Benadryl , husband pick pick up with instructions to continue to monitor and if symptoms get worse call 911.
Red, itching blotches entire trunk of body with raised bumps, flesh colored, possible fever, never checked temp.
This spontaneous report as received from a pharmacist refers to a 65 year old female patient. Pertinent medical history, drug reactions or allergies and concurrent conditions were not reported. On 16-JUL-2016 the patient was vaccinated with ZOSTAVAX, subcutaneously (Dose, anatomical location, lot number and expiration date were not provided. Concomitant therapies included BOOSTRIX. On 17-JUL-2016, the patient developed a "Bulls Eye" type rash (erythema) that was itchy(rash pruritic) and painful(rash). The patient did not sought medical attention, other than discussing with pharmacy staff. Additionally, the patient stated that she was concerned that her rash may be contagious and cause problems for her newborn grandson. It was no product quality complain involved. The outcome of the events was reported as not recovered. The causality between the therapy with ZOSTAVAX and the events was unknown. Additional information has been requested.
After 5 minutes of administering  vaccine, the patient got dizzy and fell from chair on to the floor. He was not hurt and head did not hit the ground. He was able to sit back on the chair. He informed that he gets little dizzy after getting any vaccine and feels low blood pressure but this time he felt too much dizziness. Local state police was informed in case if we needed any help for paramedics. He called his dad. He was feeling better after sometime and went with his dad.
Developed rash post SPV vaccination. Started as 3 tiny bumps, then progressed. Went to ED on the 7th re the appearance of additional lesions on trunk and extremities associated with itching. Allergy consulted and pt given antihistamines. Vaccinia PCR obtained. Seen in F/u on 11 Apr. Current lesions clearing, however new lesions developing. Scattered 2-3 mm papules on arms, legs, chest, and back. No drainage, no systemic symptoms. Steroid burst started. F/U call on 15 Apr notes that lesions have almost completely resolved, no new lesions appearing. Continues to feel well.
I got the wrong dose for booster of moderna; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (I got the wrong dose for booster of moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (I got the wrong dose for booster of moderna). At the time of the report, INCORRECT DOSE ADMINISTERED (I got the wrong dose for booster of moderna) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Reported by patients granddaughter.  Patient received second dose of Pfizer vaccine on 3/5/21.  Two days after the second dose, patient began urinating blood.  She reports that the color will change from bright ref to brownish red to darker brown.  She also shared that patient is on Xarelto.  They have been to several doctors and none of them think that the vaccine is the cause, but they wanted to share.  He is having some sort of prostate procedure this week, but she is not sure what it is.
When the certified technician administered the vaccine, as they pushed the plunger down, the vaccine started sprayed out of the administration site and ran down the patient's arm. Both the technician and the patient felt like virtually none, if any, went into the patient's arm (i.e. meaning less than half of the dose was administered). The patient's booster dose was readministered in their right arm based on the current guidance.
My mother came down with shingles approximately 2 weeks after her last shot. She never had shingles before and wasn't vaccinated.
10 AM on May 14, 2008. Given MMR + PREVNAR.  8 PM on May 14, 2008 seizure -> emergency rm -> complex febrile seizure fever.  6 AM on May 15, 2008 seizure in crib at home.
Pt had LMP on 11/27/02 with EDC on 9/03/03 and HCG 1/8/03. Pt had Anthrax IZ on 12/01/02 and 2nd on 12/14/02. Pt states screening was very clear. She did not believe she could be pregnant. Not on OCP.
AS PER MOTHER'S INFORMATION, PATIENT BEGAN HAVING  HEADACHES AND FLU LIKE SYMPTOMS WITH THE INFLUENZA VIRUS VACCINE SHE RECEIVED 10/13/05 AT HER PLACE OF WORK.  THE HEADACHES BECAME WORSE AND THE PATIENT BEGAN EXERIENCING NAUSEA AND VOMITING WHICH PROMPTED HER TO GET MEDICAL HELP 10/17/05 AT OUR FACILITY.  AS PER THE PATIENTS MOTHER'S STATEMENT, THE PATIENT RECEIVE THE INFLUENZA VIRUS VACCINE LAST YEAR WITHOUT A PROBLEM.  THE VACCINE SHE RECEIVED 10/13/05 DID CAUSE A REACTION. SHE BEGAN EXPERIENCING A  RASH TO HER NECK AND THE SITE AS PER HER SUPERVISOR AT HER PLACE OF WORK. AS PER THE ADMITTING RN AT OUR FACILITY,  THE PATIENT IS NOT ALLERGIC TO EGG OR EGG CONTAINING PRODUCTS. SHE HAS NO HISTORY OF GUILLIAN BARRE. SHE HAS NO HISTORY OF OTHER DISEASES. Infroation received from medical records states malaise, blood short eyes, ecchymosis. msv Information from discharge summary states thrombocytopenoia, hemoptosis, hematemesis, hematuria, impaired thinking. msv Medical records states cardiomegely, cholelithiasis, pulmonary edema, perepherial edema, vascular anomaly. msv
2 doses that expired 13Oct2021 were administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (2 doses that expired 13Oct2021 were administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (2 doses that expired 13Oct2021 were administered). On 19-Oct-2021, EXPIRED PRODUCT ADMINISTERED (2 doses that expired 13Oct2021 were administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication use was reported.